Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin

Gynecologic Oncology

Volumn 121, Issue 2, 2011, Pages 390-394

  Kobayashi, Yoichi ^a,b   Seino, Ken Ichiro ^a,c   Hosonuma, Shinji ^a   Ohara, Tatsuru ^a   Itamochi, Hiroaki ^d   Isonishi, Seiji ^e   Kita, Tsunekazu ^f   Wada, Haruka ^a   Kojo, Satoshi ^c   Kiguchi, Kazushige ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Interferon ; Ovarian cancer; Paclitaxel resistance; Side population

Indexed keywords

ALPHA INTERFERON; BREAST CANCER RESISTANCE PROTEIN; CISPLATIN; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; VERAPAMIL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIDE POPULATION CELL;

APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CISPLATIN; CYSTADENOCARCINOMA, SEROUS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON-ALPHA; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PACLITAXEL;

EID: 79955469335     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.12.366     Document Type: Article

References (23)

1. K. Polyak, and W.C. Hahn Roots and stems: stem cells in cancer Nat Med 12 2006 296 300 (Pubitemid 43355075)
2. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, and J. Caceres-Cortes A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 1994 645 648 (Pubitemid 24067706)
3. S.A. Bapat, A.M. Mali, C.B. Koppikar, and N.K. Kurrey Stem and progenitor-like cells contribute to the aggressive behavior of human ovarian cancer Cancer Res 65 2005 3025 3029 (Pubitemid 40524578)
4. P. Szotek, R. Pieretti-Vanmarche, P. Masiakos, D. Dinulescu, D. Connolly, and R. Foster Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian-inhibiting substance responsiveness Proc Natl Acad Sci USA 103 2006 11154 11159 (Pubitemid 44156488)
5. S. Zhang, C. Balch, M.W. Chan, H. Lai, D. Matei, and J.M. Schilder Identification and characterization of ovarian cancer-initiating cells from primary human tumors Cancer Res 68 2008 4311 4320
6. C. Wu, and B.A. Alman Side population cells in human cancers Cancer Lett 268 2008 1 9
7. G.A. Challen, and M.H. Little A side order of stem cells: the SP phenotype Stem Cells 24 2006 3 12
8. Y. Pan, and X. Huang Epithelial ovarian cancer stem cells - a review Int J Clin Exp Med 1 2008 260 266
9. M.Y. Fong, and S.S. Kakar The role of cancer stem cells and the side population in epithelial ovarian cancer Histol Histopathol 25 2010 113 120
10. A. Hadnagy, L. Gaboury, R. Beaulieu, and D. Balicki SP analysis may be used to identify cancer stem cell populations Exp Cell Res 312 2006 3701 3710 (Pubitemid 44633895)
11. S. Isonishi, M. Saitou, M. Yasuda, K. Ochiai, and T. Tanaka Enhancement of sensitivity to cisplatin by orobol is associated with increased mitochondrial cytochrome c release in human ovarian carcinoma cells Gynecol Oncol 90 2003 413 420 (Pubitemid 36952037)
12. M. Ishibashi, K. Nakayama, S. Yeasmin, A. Katahiri, K. Iida, and N. Nakayama A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer Clin Cancer Res 14 2008 3149 3155
13. S. Sato, H. Itamochi, J. Kigawa, T. Oishi, M. Shimada, and S. Sato Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy Cancer Sci 100 2009 546 551
14. C. Hemmings The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis Pathology 42 2010 105 112
15. C. Hirshmann-Jax, A.E. Foster, G.G. Wulf, J.G. Nuchtern, T.W. Jax, and U. Gobel A distinct "side population" of cells with high drug efflux capacity in human tumor cells Proc Natl Acad Sci USA 101 2004 14228 14233 (Pubitemid 39305058)
16. L. Hu, C. McArthur, and R.B. Jaffe Ovarian cancer stem-like side-population cells are tumorigenic and chemoresistant Br J Cancer 102 2010 1276 1283
17. A.A. Stravrovskaya, and T.P. Stromskaya Transport proteins of the ABC family and multidrug resistance of tumor cells Biochemistry (Moscow) 73 2008 592 604 (Pubitemid 351775081)
18. K. Yamamoto, Y. Kikuchi, K. Kudoh, and I. Nagata Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines J Cancer Res Clin Oncol 126 2000 168 172 (Pubitemid 30140217)
19. F. Morschella, E. Proiette, I. Capone, and F. Belardelli Combination strategies for enhancing the efficacy of immunotherapy in cancer patients Ann NY Acad Sci 1194 2010 169 178
20. S. Mocellin, S. Pasquali, C.R. Rossi, and D. Nitti Interferone alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis J Natl Cancer Inst 102 2010 493 501
21. N.R. Tirone, M.A. Michelin, and E.F. Murta Using cytokine to treat cervical intraepithelial and invasive neoplasia Recent Pat Anticancer Drug Discov 1 2010 165 169
22. P. Tagliaferri, M. Caraglia, A. Budillon, M. Marra, G. Vitale, and C. Viscomi New pharmacokinetic and pharmacodynamic tools for interferon- (IFN-) treatment of human cancer Cancer Immunol Immunother 54 2005 1 10 (Pubitemid 40064480)
23. L. Moserle, S. Indraccolo, M. Ghisi, C. Frasson, E. Fortunato, and S. Canecari The side population of ovarian cancer cells is a primary target of INF-α antitumor effects Cancer Res 68 2008 5658 5668